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A tropical tale of trypanosomes and snakes
The elapid N. nigricollis
is a venomous snake
(Tanzania)[4]. Since the
origins of Pharma,
venoms were used as
medicines as its toxins
target a myriad of
different physiological
processes with high
specificity and
selectivity.
Trypanosoma brucei is a parasitic
protozoan species capable to infecting
insect vectors whose bite further
produces African sleeping sickness in
human beings[1]. During parasites’
extracellular lives in the mammalian
host, its outer coat, mainly composed
of Variable surface glycoproteins
(VSGs)[2], undergoes enormous
variation in its composition to avoid
the host’s lytic immunogenic[3].
Sleeping sickness: a neglected tropical disease
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We observed VSG121 parasites using the fluorescence microscope.
Contrarily to the parasites’ phenotype during venom absence, parasites
cultured with the N. nigricollis venom show a greener and enlarged
flagellar pocket over the time.
N. nigricollis venom provokes the flagellar
pocket enlargement by accumulating GPI
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N. nigricollis’ phospholipase A2, one of the major enzymatically active
components, could be targeting the GPI anchor of VSG. The
lyophilized powder venom was diluted in HMI-9 cell culture media.
We cultured T. brucei parasites expressing eGFP attached to GPI
(VSG121) with 10µm/ml of N. nigricollis venom during 24 hours. Then,
by flow cytometry, we study the surveillance and the GFP-GPI release.
N. nigricollis venom is able to kill T. brucei by
targeting GPI anchoring of VSG
After gel-filtering 20mg of N. nigricollis lyophilized venom, we tested
each peak in culture and run a SDS PAGE further silver-stained.
PLA2 and cytotoxines are potentially the
toxins responsible of the parasite death
I. First report of using snake venom to
effectively kill effectively T. brucei.
II. Novel molecular target antigenic
variation-independent, allowing to
bypass the main inconvenience to
develop a successful treatment for the
still-today neglected sleeping sickness
disease.
Impact
III. New therapeutic window, unveiling the mechanism of parasite
lethality that may help pave the way for novel molecular tools for drug
discovery against trypanosome related diseases.
